Chemical Component Summary

Name4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-[(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide
Identifiers4-methyl-~{N}-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1~{H}-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide
FormulaC29 H27 F3 N6 O
Molecular Weight532.559
TypeNON-POLYMER
Isomeric SMILESCc1ccc(cc1C#Cc2cc3cn[nH]c3nc2)C(=O)Nc4ccc(c(c4)C(F)(F)F)CN5CCN(CC5)C
InChIInChI=1S/C29H27F3N6O/c1-19-3-5-22(14-21(19)6-4-20-13-24-17-34-36-27(24)33-16-20)28(39)35-25-8-7-23(26(15-25)29(30,31)32)18-38-11-9-37(2)10-12-38/h3,5,7-8,13-17H,9-12,18H2,1-2H3,(H,35,39)(H,33,34,36)
InChIKeyTZKBVRDEOITLRB-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count66
Chiral Atom Count0
Bond Count70
Aromatic Bond Count22

Drug Info: DrugBank

DrugBank IDDB16185 
NameHQP1351
Groups investigational
DescriptionHQP1351 is under investigation in clinical trial NCT03883100 (A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation).
Synonyms
  • Hqp-1351 free base
  • Hqp1351 free base
  • HQP1351
  • Olverembatinib
Categories
  • Acids, Carbocyclic
  • Amides
  • Benzene Derivatives
  • Benzoates
  • Hydrocarbons, Acyclic
CAS number1257628-77-5

Related Resource References

Resource NameReference
Pharos CHEMBL2316582
PubChem 51038269
ChEMBL CHEMBL2316582